Concepedia
Statistics
Publications
111
Citations
4.5K
H-Index
38
Active since
2007
Affiliations
First Affiliated Hospital of Xiamen University(Current)
Southern Medical University
Nanfang Hospital
Xiamen University
Sun Yat-sen University
Bing Xu is an author at First Affiliated Hospital of Xiamen University specializing in oncology, medicine, and pharmacology.
Publications per year
2007–2024
Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
Nga Chi Yip, Ivo S. Fombon, P Liu et al. · British Journal of Cancer · 2011 · 425 citations · Full text
Medicine, Oncology, Pharmacology +16
Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL
Ziju Y. Xu-Monette, Min Xiao, Qingyan Au et al. · Cancer Immunology Research · 2019 · 179 citations
Life Sciences, Immunology, Oncology +17
HOTTIP-dependent R-loop formation regulates CTCF boundary activity and TAD integrity in leukemia
Huacheng Luo, Ganqian Zhu, Melanie A. Eshelman et al. · Molecular Cell · 2022 · 154 citations · Full text
Life Sciences, Cancer Biology, Genetics +17
Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2
Bing Xu, Shiyun Wang, Rongwei Li et al. · Cell Death and Disease · 2017 · 143 citations · Full text
Medicine, Oncology, Pharmacology +17
Disulfiram/copper complex inhibiting NFκB activity and potentiating cytotoxic effect of gemcitabine on colon and breast cancer cell lines
Xiaoxia Guo, Bing Xu, Shuchita Pandey et al. · Cancer Letters · 2009 · 135 citations
Medicine, Oncology, Pharmacology +9
1–5 of 111